Cargando…

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy

The dosage regimen of vancomycin, teicoplanin and daptomycin remains controversial for critically ill patients undergoing continuous renal replacement therapy (CRRT). Monte Carlo simulation was applied to identify the optimal regimens of antimicrobial agents in patients with methicillin-resistant St...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiaojiao, Li, Sihan, Wang, Quanfang, Wang, Chuhui, Qiu, Yulan, Yang, Luting, Han, Ruiying, Du, Qian, Chen, Lei, Dong, Yalin, Wang, Taotao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031498/ https://www.ncbi.nlm.nih.gov/pubmed/35456676 http://dx.doi.org/10.3390/pharmaceutics14040842

Ejemplares similares

Central Nervous System Toxicity of Voriconazole: Risk Factors and Threshold – A Retrospective Cohort Study
por: Yang, Luting, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients
por: Han, Ruiying, et al.
Publicado: (2021)

Choosing Optimal Antibiotics for the Treatment of Patients Infected With Enterobacteriaceae: A Network Meta-analysis and Cost-Effectiveness Analysis
por: Han, Ruiying, et al.
Publicado: (2021)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Colonization and infection by MRSA in critically ill patients
por: Lorente, L, et al.
Publicado: (2007)

MRSA: the transmission paradigm investigated
por: Moore, G, et al.
Publicado: (2011)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Antimicrobial peptide GL13K immobilized onto SLA-treated titanium by silanization: antibacterial effect against methicillin-resistant Staphylococcus aureus (MRSA)
por: Li, Yusang, et al.
Publicado: (2022)

Metallo-β-lactamases immobilized by magnetic zeolitic imidazolate frameworks-8 for degradation of β-lactam antibiotics in an aqueous environment
por: Wang, Quanfang, et al.
Publicado: (2023)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Body temperature and infection in critically ill patients on continuous kidney replacement therapy
por: Challener, Douglas W., et al.
Publicado: (2023)

Citrate Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Patients: Success and Limits
por: Mariano, Filippo, et al.
Publicado: (2011)

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Samtani, Mahesh N., et al.
Publicado: (2012)

Glutamine serum, adherence and losses in continuous renal replacement therapies in critically ill patients
por: Rodigues, MG, et al.
Publicado: (2005)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Post-mortem findings in critically ill patients treated with continuous renal replacement therapy
por: Crippa, IA, et al.
Publicado: (2015)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Evaluation of the registry DIALYREG for the assessment of continuous renal replacement techniques in the critically ill patient
por: González-Fernández, M., et al.
Publicado: (2023)

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients
por: Buitinck, Sophie H., et al.
Publicado: (2022)

Research on the Application Effect of Strengthening Risk Management in Continuous Renal Replacement Therapy Nursing of Critically Ill Patients
por: Yang, Huimei, et al.
Publicado: (2022)

Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China
por: Chen, Hongbin, et al.
Publicado: (2021)

Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
por: Wang, Chuhui, et al.
Publicado: (2021)

Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review
por: Chen, Han, et al.
Publicado: (2014)

Toxic epidermal necrolysis: a paradigm of critical illness
por: Estrella-Alonso, Alfonso, et al.
Publicado: (2017)

Effect of Continuous Renal Replacement Therapy with the oXiris Hemofilter on Critically Ill Patients: A Narrative Review
por: Li, Yupei, et al.
Publicado: (2022)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
por: Omrani, Ali S., et al.
Publicado: (2015)

Outcome of continuous renal replacement therapy in critically ill children: a retrospective cohort study
por: Al-Ayed, Tareq, et al.
Publicado: (2018)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

Continuous Renal Replacement Therapy (CRRT) for Nonrenal Indications among Critically Ill Children with Malignancy
por: Hui, Wun Fung, et al.
Publicado: (2021)

Continuous Renal Replacement Therapy in the Critically Ill Patient: From Garage Technology to Artificial Intelligence
por: Samoni, Sara, et al.
Publicado: (2021)

Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials
por: Zhou, Zhifeng, et al.
Publicado: (2023)

Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
por: Ricci, Zaccaria, et al.
Publicado: (2006)

Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study
por: Santiago, Maria J, et al.
Publicado: (2009)

Influence of Daily Fluid Balance prior to Continuous Renal Replacement Therapy on Outcomes in Critically Ill Patients
por: Han, Min Jee, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s9f50gjbvllkukj1u6j07uaqcg